Barclays analyst Mathieu Robilliard raised the firm’s price target on Iridium to $44 from $42 and keeps an Overweight rating on the shares. The company’s Q1 results together with the acquisition of STL are evidence that it operates in segments with growth opportunities, the analyst tells investors in a research note.